Literature DB >> 30948875

Outcome of 150 Consecutive Blumgart's Pancreaticojejunostomy After Pancreaticoduodenectomy.

Mallika Tewari1, R Mahendran1, T Kiran1, A Verma2, V K Dixit3, S Shukla3, H S Shukla1.   

Abstract

Postoperative pancreatic fistula (POPF) is the most feared complication after pancreaticoduodenectomy (PD) that leads to intra-abdominal abscess, sepsis, or bleeding and remains the single most important source of morbidity and mortality after PD. To minimize this dreaded complication, various surgical techniques and modifications of pancreaticoenteric reconstruction have been proposed. However, still POPF does occur even in experienced hands. We herein describe the outcome of 150 post PD patients who underwent duct-to-mucosa (DM) pancreaticojejunostomy (PJ) using a special technique, Blumgart's "through &amp; through" U transpancreatic sutures. The technique is described in detail. Postoperative octreotide and metoclopramide were used in all patients for 3 days. An enhanced recovery (ERAS) protocol was followed in a subset of patients. All patients were ASA grade 1 and had adenocarcinoma of the periampullary region/pancreatic head and underwent standard pylorus resecting PD after due optimization. Eighty-eight (58.7%) patients had pancreatic duct < 3 mm and pancreatic texture was soft to very soft in 112 (74.6%) patients. There was only one International Study Group of Pancreatic Surgery (ISGPS) grade C POPF with concomitant hemorrhage. Five patients developed ISGPS grade B and two grade C, delayed gastric emptying (DGE). There was no 30-day mortality. The average length of hospital stay was 7.3 ± 4.2 days with a median of 6 days in the ERAS subset of patients. Blumgart's "through &amp; through" DMPJ technique is very helpful in reducing the POPF and other complications even in high-risk pancreas (i.e., soft with a small pancreatic duct) and is easy to learn and perform.

Entities:  

Keywords:  Delayed gastric emptying; Enhanced recovery protocol; Pancreatic cancer; Pancreatic fistula; Pancreaticoduodenectomy; Pancreaticojejunostomy; Periampullary cancer; Post pancreatectomy hemorrhage

Year:  2018        PMID: 30948875      PMCID: PMC6414584          DOI: 10.1007/s13193-018-0821-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  33 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Postoperative pancreatic fistula: an international study group (ISGPF) definition.

Authors:  Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

3.  Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).

Authors:  Moritz N Wente; Claudio Bassi; Christos Dervenis; Abe Fingerhut; Dirk J Gouma; Jakob R Izbicki; John P Neoptolemos; Robert T Padbury; Michael G Sarr; L William Traverso; Charles J Yeo; Markus W Büchler
Journal:  Surgery       Date:  2007-11       Impact factor: 3.982

4.  SURGICAL MANAGEMENT OF CARCINOMA OF THE AMPULLA OF VATER AND OF THE PERIAMPULLARY PORTION OF THE DUODENUM.

Authors:  V C Hunt
Journal:  Ann Surg       Date:  1941-10       Impact factor: 12.969

5.  Pancreaticojejunostomy and Other Problems Associated With the Surgical Management of Carcinoma Involving the Head of the Pancreas: Report of Five Additional Cases of Radical Pancreaticoduodenectomy.

Authors:  C G Child
Journal:  Ann Surg       Date:  1944-06       Impact factor: 12.969

Review 6.  Options of restorative pancreaticoenteric anastomosis following pancreaticoduodenectomy: a review.

Authors:  Mallika Tewari; Priya Hazrah; Vinay Kumar; Hari S Shukla
Journal:  Surg Oncol       Date:  2009-02-20       Impact factor: 3.279

7.  Blumgart anastomosis for pancreaticojejunostomy minimizes severe complications after pancreatic head resection.

Authors:  A Kleespies; M Rentsch; H Seeliger; M Albertsmeier; K-W Jauch; C J Bruns
Journal:  Br J Surg       Date:  2009-07       Impact factor: 6.939

Review 8.  Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations.

Authors:  Kristoffer Lassen; Mattias Soop; Jonas Nygren; P Boris W Cox; Paul O Hendry; Claudia Spies; Maarten F von Meyenfeldt; Kenneth C H Fearon; Arthur Revhaug; Stig Norderval; Olle Ljungqvist; Dileep N Lobo; Cornelis H C Dejong
Journal:  Arch Surg       Date:  2009-10

Review 9.  Multimodal strategies to improve surgical outcome.

Authors:  Henrik Kehlet; Douglas W Wilmore
Journal:  Am J Surg       Date:  2002-06       Impact factor: 2.565

Review 10.  Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition.

Authors:  Moritz N Wente; Johannes A Veit; Claudio Bassi; Christos Dervenis; Abe Fingerhut; Dirk J Gouma; Jakob R Izbicki; John P Neoptolemos; Robert T Padbury; Michael G Sarr; Charles J Yeo; Markus W Büchler
Journal:  Surgery       Date:  2007-07       Impact factor: 3.982

View more
  2 in total

1.  Association of a Modified Blumgart Anastomosis With the Incidence of Pancreatic Fistula and Operation Time After Laparoscopic Pancreatoduodenectomy: A Cohort Study.

Authors:  Yong-Gang He; Xiao-Min Yang; Xue-Hui Peng; Jing Li; Wen Huang; Gui-Cang Jian; Jing Wu; Yi-Chen Tang; Liang Wang; Xiao-Bing Huang
Journal:  Front Surg       Date:  2022-06-27

2.  Blumgart anastomosis reduces the incidence of pancreatic fistula after pancreaticoduodenectomy: a systematic review and meta-analysis.

Authors:  Zhenlu Li; Ailin Wei; Ning Xia; Liangxia Zheng; Dujiang Yang; Jun Ye; Junjie Xiong; Weiming Hu
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.